Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ce9be8d9-0a69-403e-be71-08092725dd72
Date 8/28/2014
Company Name OncoPep
Mailing Address 520 Boston Street North Andover, MA 01845 USA
Company Description OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The Company’s proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute.
Proceeds Purposes Proceeds raised will support the clinical development of PVX-410, currently being studied in patients with smoldering multiple myeloma (SMM), an asymptomatic stage of MM.